home.social

#radiopharmaceuticals — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #radiopharmaceuticals, aggregated by home.social.

  1. DATE: July 10, 2025 at 05:15PM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    Actithera raises $75M #seriesA for FAP-targeted #radiopharmaceuticals

    t.co/sY7HjOYryk

    #medtech

    Here are any URLs found in the article text:

    t.co/sY7HjOYryk

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  2. GSK, after 11-month romance, buys oligonucleotide partner Elsie for up to $50M—FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety — FDA panel recommends new COVID vaccines for JN.1 lineage by fall—bit.ly/w28kSd #gsk #oligonucleotides #fda #elililly #alzheimers #covid19 #vaccines #mergersandacquisitions #radiopharmaceuticals #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  3. AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal—In his final full year as AbbVie's CEO, Richard Gonzalez collects $25.7M in total pay—Bayer cues up filings for rival to Astellas’ menopause drug--bit.ly/w28kSd #astrazeneca #mergersandacquisitions #radiopharmaceuticals #pharmaceos #executivecompensation #abbvie #bayer #hotflashes #menopause #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  4. AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal—In his final full year as AbbVie's CEO, Richard Gonzalez collects $25.7M in total pay—Bayer cues up filings for rival to Astellas’ menopause drug--bit.ly/w28kSd #astrazeneca #mergersandacquisitions #radiopharmaceuticals #pharmaceos #executivecompensation #abbvie #bayer #hotflashes #menopause #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  5. AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal—In his final full year as AbbVie's CEO, Richard Gonzalez collects $25.7M in total pay—Bayer cues up filings for rival to Astellas’ menopause drug--bit.ly/w28kSd #astrazeneca #mergersandacquisitions #radiopharmaceuticals #pharmaceos #executivecompensation #abbvie #bayer #hotflashes #menopause #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  6. Congratulations to this multidisciplinary research team co-lead by #UBC Medicine's François Bénard and #SFUChemistry assistant professor Caterina Ramogida! They been awarded over $23 million in federal funding to develop new #radiopharmaceuticals to treat many different kinds of cancers, including end-stage metastatic cancers with few treatment options. med.ubc.ca/news/nuclear-medici #oncology #nuclearmedicine #cancer #sfuscience #sfu

  7. Lots of folks in #nucmed and #radonc are interested in launching their own #radiopharmaceuticals ☢️therapy program, but not sure where to start.

    If you're in this camp, you're in luck!🍀

    @[email protected] and the team @[email protected] put together this comprehensive guide!

    👇👇👇

    onlinelibrary.wiley.com/doi/ab

  8. #introductions

    Hi Mastodonians, MastoDons, & MastoDoñas!

    I am an oncologist and scientist at the NCI developing #radiopharmaceuticals in the lab to help image and treat cancer.

    My research sits at the interface of #oncology #chemistry #radiochemistry #DrugDevelopment #ClinicalTrials #nucmed #radonc.

    Beyond the professional, I enjoy #audiobooks, #fitness, #coffee, and occasional #beer #homebrewing.

    Looking to connect with and learn from diverse thinkers in oncology, medicine, and beyond.